Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Multi-Drug Resistant Organisms Are Common in Fecal Surveillance Cultures and Do Not Predict Bacteremia but Correlate with Poorer Outcomes in Patients Undergoing Allogeneic Stem Cell Transplants

Vikram Mathews, MD DM, Alok Srivastava, Biju George, MD DM, Anu Korula, MD DM, Susmitha Perumalla, MD, Fouzia Nambiathayil Abubacker, DM, Nisham P N, MD D.M, Anup Devasia, MD D.M, Aby Abraham, MD DM, Veeraraghavan Balaji, MD, Kavitha M Lakshmi, MSc

Blood (2016) 128 (22): 3406.

https://doi.org/10.1182/blood.V128.22.3406.3406

Published: 2016

Journal Articles

Fate of Ikaros in Multiple Myeloma Cells upon Treatment with Lenalidomide and Proteasome Inhibitor

Saravanan Ganesan, MSc, Nithya Balasundaram, MSc, Hamenth Kumar Palani, MSc, Ansu Abu Alex, MSc, Sachin David, MSc, Anup Joseph Devasia, MD DM, Biju George, MD DM, Poonkuzhali Balasubramanian, MSc PhD, Vikram Mathews, MD DM

Blood (2016) 128 (22): 3281.

https://doi.org/10.1182/blood.V128.22.3281.3281

Published: 2016

Journal Articles

Metabolic Rewiring Drives Resistance to Arsenic Trioxide in Acute Promyelocytic Leukemia

Nithya Balasundaram, MSc, Saravanan Ganesan, MSc, Hamenth Kumar Palani, MSc, Ansu Abu Alex, MSc, Sachin David, MSc, Anu Korula, MD DM, Biju George, MD DM, Christine Chomienne, MD PhD, Poonkuzhali Balasubramanian, MSc PhD, Vikram Mathews, MD DM

Blood (2016) 128 (22): 3956.

https://doi.org/10.1182/blood.V128.22.3956.3956

Published: 2016

Journal Articles

Role of Pre-Transplant Cardiac and Hepatic T2* Magnetic Resonance for Risk Assessment in Patients with Thalassemia Major Undergoing an Allogeneic Stem Cell Transplantation

Vikram Mathews, MD DM, Alfred Inbaraj, MD, Anu Korula, MD DM, Nisham PN, MD DM, Fouzia NA, Dip NB, DM,, Anup Joseph Devasia, MD DM, Kavitha M Lakshmi, MSc, Aby Abraham, MD DM, Aparna Irodi, MD, Biju George, MD DM, Elizabeth Joseph, DMRD, DNB, Alok Srivastava

Blood (2016) 128 (22): 2200.

https://doi.org/10.1182/blood.V128.22.2200.2200

Published: 2016

Journal Articles

Second Hematopoietic SCT for Thalassemia Major: Improved Clinical Outcomes with a Treosulfan Based Conditioning Regimen

Vikram Mathews, MD DM, Anu Korula, MD DM, Nisham PN, MD DM, Anup Joseph Devasia, MD DM, Fouzia NA, Dip NB, DM,, Kavitha M Lakshmi, MSc, Aby Abraham, MD DM, Biju George, MD DM, Alok Srivastava

Blood (2016) 128 (22): 2201.

https://doi.org/10.1182/blood.V128.22.2201.2201

Published: 2016

Journal Articles

Alteration of the Hematopoietic Components, Mesenchymal Stromal Cells and Vascular Elements in the Bone Marrow Niche in Myelodysplastic Syndrome: Refractory Cytopenia with Multilineage Dysplasia

Salar Abbas, M.Sc, Aparna Venkatraman, PhD, Sanjay Kumar, PhD, Archana Kini, M.Sc, Marie Therese Manipadam, MD, Vivi M Srivastava, MD, Eunice Sindhuvi, PhD, Vikram Mathews, MD DM, Biju George, MD DM, Alok Srivastava

Blood (2016) 128 (22): 5516.

https://doi.org/10.1182/blood.V128.22.5516.5516

Published: 2016

Journal Articles

Osteoblast Differentiation of Stromal Cells Induced By Leukemic Cells

Saravanan Ganesan, MSc, Hamenth Kumar Palani, MSc, Vairavan Lakshmanan, B.Tech, Nithya Balasundaram, MSc, Ansu Abu Alex, MSc, Sachin David, MSc, Biju George, MD DM, Poonkuzhali Balasubramanian, MSc PhD, Neha Vyas, PhD, Dasaradhi Palakodeti, PhD, Vikram Mathews, MD DM

Blood (2016) 128 (22): 5062.

https://doi.org/10.1182/blood.V128.22.5062.5062

Published: 2016

Journal Articles

Role of miRNA in Micro-Environment Mediated Drug Resistance in Acute Promyelocytic Leukemia to Arsenic Trioxide

Saravanan Ganesan, MSc, Vairavan Lakshmanan, B.Tech, Hamenth Kumar Palani, MSc, Nithya Balasundaram, MSc, Ansu Abu Alex, MSc, Sachin David, MSc, Anu Korula, MD DM, Biju George, MD DM, Poonkuzhali Balasubramanian, MSc PhD, Harsha Gowda, PhD, Neha Vyas, PhD, Dasaradhi Palakodeti, PhD, Vikram Mathews, MD DM

Blood (2016) 128 (22): 5125.

https://doi.org/10.1182/blood.V128.22.5125.5125

Published: 2016

Journal Articles

Management of Relapsed Acute Promyelocytic Leukemia Post ATO Upfront Therapy: Open-Labeled Phase II Study Evaluating Role of Proteasome Inhibition

Vikram Mathews, MD DM, Anu Korula, MD DM, Uday Kulkarni, MD, Saravanan Ganesan, MSc, Sachin David, MSc, Ansu Abu Alex, MSc, Nisham PN, MD DM, Aby Abraham, MD DM, Alok Srivastava, Kavitha M Lakshmi, MSc, Poonkuzhali Balasubramanian, MSc PhD, Biju George, MD DM

Blood (2016) 128 (22): 446.

https://doi.org/10.1182/blood.V128.22.446.446

Published: 2016

Journal Articles

A 5'UTR Polymorphism in NT5E Gene Influences Outcome in Patients with Acute Myeloid Leukemia Undergoing Hematopoietic Stem Cell Transplantation with Fludarabine Based Conditioning Regimen

Ezhilpavai Mohanan, MSc, John C Panetta, PhD, Kavitha M Lakshmi, MSc, Anup Joseph Devasia, MD DM, Nisham PN, MD DM, Anu Korula, MD DM, Fouzia NA, Dip NB, DM,, Aby Abraham, MD DM, Biju George, MD DM, Alok Srivastava, Vikram Mathews, MD DM, Poonkuzhali Balasubramanian, MSc PhD

Blood (2016) 128 (22): 984.

https://doi.org/10.1182/blood.V128.22.984.984

Published: 2016

Journal Articles

Allogeneic Transplant In Children with Severe Aplastic Anemia – Excellent Outcomes with the Use of a Fludarabine Based Conditioning Regimen

Biju George, MD, DM, Vikram Mathews, MD, Auro Viswabandhya, Aby Abraham, Lakshmi M Kavitha, Mammen Chandy, MD, Alok Srivastava, MD

Blood (2010) 116 (21): 3519.

https://doi.org/10.1182/blood.V116.21.3519.3519

Published: 2010

Journal Articles

Trough Level of First Dose of Busulfan (Cmin1) Is a Stronger Predictor of Graft Rejection Than Steady State Concentration (Css1) In Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Poonkuzhali Balasubramanian, Ph.D, Salamun Desire, M.Sc, Pranavi Sugumaran, M.Sc, Kavitha ML, M.Sc, Aby Abraham, MD, DM, Auro Viswabandya, MD, DM, Biju George, MD, DM, Vikram Mathews, MD, DM, Mammen Chandy, MD, Rajagopal Krishnamoorthy, D.Sc, Alok Srivastava, MD

Blood (2010) 116 (21): 518.

https://doi.org/10.1182/blood.V116.21.518.518

Published: 2010

Journal Articles

Autologous Stem Cells as Backup for Patients Undergoing Allogeneic Related Transplant for Thalassemia Major.

Mammen Chandy, MD, Uday Deotare, MD, DM, Chidambaram S, BSc, Kavitha M Lakshmi, MSc, Vikram Mathews, MD, DM, Biju George, MD, DM, Auro Vishwabandhya, MD, DM, Rajashekar T, MD, DM, Alok Srivastava, MD

Blood (2009) 114 (22): 4539.

https://doi.org/10.1182/blood.V114.22.4539.4539

Published: 2009

Journal Articles

A Low Intensity Protocol of Fludarabine, Busulfan and Cyclophosphamide Reduces Toxicity without Compromising Engraftment in Children Undergoing Allogeneic Bone Marrow Transplantation for Beta Thalassaemia Major.

Biju George, MD, DM, Vikram Mathews, MD, DM, Auro Viswabandhya, MD, DM, Mammen Chandy, MD, FRACP, FRCPA, Alok Srivastava, MD, FRACP, FRCP

Blood (2006) 108 (11): 5366.

https://doi.org/10.1182/blood.V108.11.5366.5366

Published: 2006

Journal Articles

Oral Prednisolone Produces a Durable Response in Pediatric Myelodysplastic Syndromes (MDS).

Mammen Chandy, MD, FRACP, FRCPA, Biju George, MD, DM, Vikram Mathews, MD, DM, Auro Viswabandya, MD, DM, Ashish Bajel, MD, DM, Alok Srivastava, MD, FRACP, FRCPA

Blood (2005) 106 (11): 4906.

https://doi.org/10.1182/blood.V106.11.4906.4906

Published: 2005

Journal Articles

Fludarabine Based Conditioning for Allogeneic Transplantation in Severe Aplastic Anemia.

Mammen Chandy, MD, FRACP, FRCPA, Biju George, MD, DM, Auro Viswabandya, MD, DM, Vikram Mathews, MD, DM, Ashish Bajel, MD, DM, Alok Srivastava, MD, FRACP, FRCPA

Blood (2005) 106 (11): 2029.

https://doi.org/10.1182/blood.V106.11.2029.2029

Published: 2005

Journal Articles

The Role of Donor Lymphocyte Infusion (DLI) and Imatinib Mesylate in the Treatment of Relapse after Allogenic Stem Cell Transplant for Chronic Myeloid Leukemia.

Mammen Chandy, MD, FRACP, FRCPA, Uday Deotare, MD, Biju George, MD, DM, Vikram Mathews, MD, DM, Auro Viswabandya, MD, DM, Ashish Bajel, MD, DM, Alok Srivastava, MD, FRACP, FRCPA

Blood (2005) 106 (11): 5393.

https://doi.org/10.1182/blood.V106.11.5393.5393

Published: 2005

Journal Articles

A Pilot Study of Rabbit Antithymocyte Globulin - TECELAC Combined with Cyclosporine and Prednisolone as Immunosuppressive Therapy for Severe Aplastic Anemia.

Mammen Chandy, MD, FRACP, FRCPA, Biju George, MD, DM, Auro Viswabandya, MD, DM, Ashish Bajel, MD, DM, Vikram Mathews, MD, DM, Alok Srivastava, MD, FRACP, FRCPA

Blood (2005) 106 (11): 3749.

https://doi.org/10.1182/blood.V106.11.3749.3749

Published: 2005

Journal Articles

Arsenic Trioxide (As 2 O 3 ) in the Treatment of Patients with Newly Diagnosed Acute Promyelocytic Leukemia (APML) - Toxicity and Outcome.

Biju George, MD, DM, Vikram Mathews, MD, DM, Auro Vishwabandhya, MD, DM, Alok Srivastava, MD, FRCPA, Mammen Chandy, MD, FRCPA

Blood (2004) 104 (11): 889.

https://doi.org/10.1182/blood.V104.11.889.889

Published: 2004

Journal Articles

Pharmacogenetics of Cyclophosphamide in Patients with Beta Thalassemia Major Undergoing Bone Marrow Transplantation.

Balasubramanian Poonkuzhali, Ph.D., Desire Salamun, M.Sc, Ramachandran V. Shaji, Ph.D., Biju George, MD, DM, Vikram Mathews, MD, DM, Mammen Chandy, MD, Rajagopal Krishnamoorthy, Ph.D., Alok Srivastava, MD

Blood (2004) 104 (11): 99.

https://doi.org/10.1182/blood.V104.11.99.99

Published: 2004

NARROW

Multi-Drug Resistant Organisms Are Common in Fecal Surveillance Cultures and Do Not Predict Bacteremia but Correlate with Poorer Outcomes in Patients Undergoing Allogeneic Stem Cell Transplants

Fate of Ikaros in Multiple Myeloma Cells upon Treatment with Lenalidomide and Proteasome Inhibitor

Metabolic Rewiring Drives Resistance to Arsenic Trioxide in Acute Promyelocytic Leukemia

Role of Pre-Transplant Cardiac and Hepatic T2* Magnetic Resonance for Risk Assessment in Patients with Thalassemia Major Undergoing an Allogeneic Stem Cell Transplantation

Second Hematopoietic SCT for Thalassemia Major: Improved Clinical Outcomes with a Treosulfan Based Conditioning Regimen

Alteration of the Hematopoietic Components, Mesenchymal Stromal Cells and Vascular Elements in the Bone Marrow Niche in Myelodysplastic Syndrome: Refractory Cytopenia with Multilineage Dysplasia

Osteoblast Differentiation of Stromal Cells Induced By Leukemic Cells

Role of miRNA in Micro-Environment Mediated Drug Resistance in Acute Promyelocytic Leukemia to Arsenic Trioxide

Management of Relapsed Acute Promyelocytic Leukemia Post ATO Upfront Therapy: Open-Labeled Phase II Study Evaluating Role of Proteasome Inhibition

A 5'UTR Polymorphism in NT5E Gene Influences Outcome in Patients with Acute Myeloid Leukemia Undergoing Hematopoietic Stem Cell Transplantation with Fludarabine Based Conditioning Regimen

Allogeneic Transplant In Children with Severe Aplastic Anemia – Excellent Outcomes with the Use of a Fludarabine Based Conditioning Regimen

Trough Level of First Dose of Busulfan (Cmin1) Is a Stronger Predictor of Graft Rejection Than Steady State Concentration (Css1) In Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Autologous Stem Cells as Backup for Patients Undergoing Allogeneic Related Transplant for Thalassemia Major.

A Low Intensity Protocol of Fludarabine, Busulfan and Cyclophosphamide Reduces Toxicity without Compromising Engraftment in Children Undergoing Allogeneic Bone Marrow Transplantation for Beta Thalassaemia Major.

Oral Prednisolone Produces a Durable Response in Pediatric Myelodysplastic Syndromes (MDS).

Fludarabine Based Conditioning for Allogeneic Transplantation in Severe Aplastic Anemia.

The Role of Donor Lymphocyte Infusion (DLI) and Imatinib Mesylate in the Treatment of Relapse after Allogenic Stem Cell Transplant for Chronic Myeloid Leukemia.

A Pilot Study of Rabbit Antithymocyte Globulin - TECELAC Combined with Cyclosporine and Prednisolone as Immunosuppressive Therapy for Severe Aplastic Anemia.

Arsenic Trioxide (As 2 O 3 ) in the Treatment of Patients with Newly Diagnosed Acute Promyelocytic Leukemia (APML) - Toxicity and Outcome.

Pharmacogenetics of Cyclophosphamide in Patients with Beta Thalassemia Major Undergoing Bone Marrow Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only